Paris, France and Camberley, UK – 18 March 2022 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that it was notified on 18 March 2022 that Jean-Pierre Crinelli, a Non-Executive Director of Novacyt, acquired 3,208 ordinary shares in the Company at a price of €2.41 per share. Following the transaction, Mr Crinelli is interested in 33,981 ordinary shares representing 0.05% of the issued share capital.
http://novacyt.com/wp-content/uploads/2022/03/Novacyt-Director-Dealings.pdf